Camidge Camidge DR DR Kim Kim HR HR Ahn Ahn M-J M-J Yang Yang JC-H JC-H Han Han J-Y J-Y Lee Lee J-S J-S Brigatinib versus Crizotinib in ALK-positive non-small-cell lung cancer Brigatinib versus Crizotinib in ALK-positive non-small-cell lung cancer N Engl J Med N Engl J Med 2018 2018 379 379 21 21 2027 2027 2039 2039 10.1056/NEJMoa1810171 10.1056/NEJMoa1810171 supplied-pmid 30280657? The gene discussed is ALK; the disease is non-small cell lung carcinoma.